AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04609514 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smartphone coaching
Description: All participants will partake in over-the-phone smartphone coaching lead by the PI or a research assistant. This will be a time for participants to bring up any technical issues they are experiencing with the study smartphone or app.
Study NCT04609514 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smartphone coaching
Description: All participants will partake in over-the-phone smartphone coaching lead by the PI or a research assistant. This will be a time for participants to bring up any technical issues they are experiencing with the study smartphone or app.
Study NCT06230263 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Visual acuity test
Description: Assess near high-contrast visual acuity (40cm) using EyeChart PRO on an iPad.~Use the MNREAD app to measure:~Reading Acuity: Smallest font size read without errors. Critical Print Size: Smallest font size for peak reading speed. Maximum Reading Speed: Time to read comfortable font size, in words per minute. Reading Accessibility Index: Single metric summarizing visual access to print. Assess near visual function with the Near Activity Visual Questionnaire.~Evaluate distance visual acuity, both high and low contrast, using logMAR and the E-ETDRS (NIDEK SC-2000).
Study NCT06230263 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Visual acuity test
Description: Assess near high-contrast visual acuity (40cm) using EyeChart PRO on an iPad.~Use the MNREAD app to measure:~Reading Acuity: Smallest font size read without errors. Critical Print Size: Smallest font size for peak reading speed. Maximum Reading Speed: Time to read comfortable font size, in words per minute. Reading Accessibility Index: Single metric summarizing visual access to print. Assess near visual function with the Near Activity Visual Questionnaire.~Evaluate distance visual acuity, both high and low contrast, using logMAR and the E-ETDRS (NIDEK SC-2000).
Study NCT06201312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COP exercise
Description: crossover point intensity exercise
Study NCT04890808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inosine
Description: Patients will be dosed with two 500 mg capsules of Inosine twice daily for 36 months
Study NCT04890808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: IP6
Description: Patients will be dosed with two 500 mg capsules of IP6 twice daily for 36 months
Study NCT03303222 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: breath
Description: measurement of volatile compounds, such as TMAO in exhaled breath and blood
Study NCT04807673 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Neoadjuvant period: pembrolizumab 200mg IV D1, Q3W, and preoperative therapy with three cycles.~Adjuvant period: pembrolizumab 200 mg IV D1, Q3W, up to one year, which should be performed within 3-6 weeks after surgery.
Study NCT04807673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Neoadjuvant period: paclitaxel 135mg/m\^2 IV on Day 2 Q3W, and a total of three cycles.
Study NCT04807673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Neoadjuvant period: cisplatin 80 mg/m\^2 IV on Day 2 Q3W, and a total of three cycles.
Study NCT06523712 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smile Smarts
Description: The interactive oral health care lessons provided to participants in Arm 1 would involve activities and discussions aimed at changing behaviors such as tooth brushing frequency, brushing techniques, and the use of interdental aids. The intervention aims to educate and motivate participants to adopt and maintain optimal oral hygiene habits through behavioral change strategies.
Study NCT04807673 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoradiotherapy
Description: neoadjuvant chemoradiotherapy 41.4Gy(1.8Gy×23 fractions) with five cycles of TP(Paclitaxel 50mg/m\^2 on D1 and Cisplatin 25mg/m\^2 D1, repeated every week
Study NCT04357054 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Darwish test
Description: Infertile women planned for combined laparoscopy and hysteroscopy as an integral part of infertility wok-up.
Study NCT06204445 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green coffee
Description: Each cup of coffee provides approximately 400 mg of hydroxycinnamic acids.
Study NCT06204445 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Roasted coffee
Description: Each cup of coffee provides approximately 150 mg of hydroxycinnamic acids.
Study NCT05656235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin
Description: Enfortumab vedotin 1.25mg/kg on Days 1 and 8 every 3 weeks for up to 35 weeks (each cycle = 21 days)
Study NCT05656235 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200mg on Day 1 every 3 weeks for up to 35 weeks (each cycle = 21 days)
Study NCT06241547 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electrical stimualtion via EmeTerm bracelet
Description: We planned to exert electrical stimulation via the bracelet.
Study NCT06241547 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: antimetic drugs（ dexamethasone，ondansetron）
Description: Antimetic drugs (dexamethasone ondansetron) are used to prevent postoperative nausea and vomiting.
Study NCT06241547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: antimetic drugs（ dexamethasone，ondansetron）
Description: Antimetic drugs (dexamethasone ondansetron) are used to prevent postoperative nausea and vomiting.
Study NCT04744272 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: myAsthma
Description: myAsthma is an online digital self-management application to support asthma patients by offering education, inhaler technique, pulmonary rehabilitation, symptoms and medication usage tracking remotely.
Study NCT05589805 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy
Description: In addition to wrist splint, ESWT treatment (1.5 bar, 5Hz, 1000 beats) will be applied to the patients with Elmed Vibrolith Ortho brand ESWT device, which we routinely use in the treatment of carpal tunnel syndrome, for 3 weeks, once a week.
Study NCT05589805 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser therapy
Description: In addition to the wrist splint, the patients will be treated with the BTL-4110 Laser Topline model low-intensity laser device, which we routinely use in the treatment of carpal tunnel syndrome in our hospital, 5 days a week for 15 sessions of laser treatment.
Study NCT05589805 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Patients will only be given a wrist splint to keep the wrist in neutral position.
Study NCT04733027 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Dose escalation, first-in-human phase I clinical trial with an Expansion phase
Description: PEP-010 will be administered on days 1, 2 and 3 every week, as a 3-hour intravenous infusion. Treatment will be administered until disease progression, unacceptable toxicity, death or withdrawal of consent, whichever occurs first. Each cycle will be of 21 days duration.
Study NCT05436197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PLAYshop Program
Description: The intervention includes: 1. Educational Training - the 60 min virtual/hybrid workshop will be delivered by a trained facilitator. Parents will be introduced to physical literacy via education, group discussion, and active participation in fundamental movement skills (FMS) based activities with their child. 2. Distribution of Education Resources- Parents will be provided with physical literacy and physical activity printed resources. 3. Material resources -parents will also be provided a bag of inexpensive active play equipment (e.g., ball, bean bag, balloons). 4. Provide Follow-up Support- After the workshop, participants will gain access to an app with an online toolkit including new active play ideas, tips, and equipment they can make at home for active play. Additionally, participants will receive four bi-weekly booster lessons that include key workshop messages, support and encouragement for parents, reflection and check-in questions, and new activities to try with their child.
Study NCT06172751 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: not applicable, this is an observational retrospective data analysis study; no interventions in the study
Study NCT05070442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Norm-based messaging and peer comparison features
Description: Participants are shown a version of NUSMart which includes Nutri-Score labels that are enabled and displayed besides all the products in the store. Additionally, they are shown a video that gives them background information about Nutri-Score labels and describes the following features enabled in this intervention:~* Norm-based messaging will be displayed in the form of a happy or sad emoticon based on whether the participant's current basket average Nutri-Score (weighted by number of servings) is above or below other shoppers (Nutri-Score=3.98).~* Peer comparison will be implemented as a vertical ruler display of the participant's current basket average Nutri-Score (weighted by number of servings) as well as that of their peers.~Nutri-Score=3.98 was chosen as it is 10% better than the mean Nutri-Score of baskets purchased by participants in the Nutri-Score labelled intervention arm of a prior study.
Study NCT05070442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Incentives leveraging on loss aversion
Description: Participants are informed that they have received an additional $5 towards their participant reimbursement. However, this amount will be forfeited if they check-out with a basket average Nutri-Score (weighted by the number of servings) that falls below the average Nutri-Score of other shoppers i.e. 3.98. An indicator on the screen that informs the participants of this potential forfeiting will be included.
Study NCT06371859 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: XAI feedback on MCA/UA Doppler spectral curves and gate placement suggestions
Description: This study includes 1840 ultrasound images, split into UA and MCA flow and spectrum images, each duplicated for a total of 3680 images to compare explainable AI (XAI) feedback vs. no feedback. The investigators will provide matched sets of 40 images (one for the XAI group and one for the non-XAI group) to participants. Participants are matched based on their level of experience within each hospital (Resident physicians, obstetricians, and gynecologists with obstetric ultrasound experience).~All participants are instructed to place gates on the flow images of the umbilical artery and the middle cerebral artery and to assess the quality of the resulting flow curves. Specifically, for flow images, participants must identify the most appropriate gate placement. For spectral flow curves, they are to decide if the curves are of sufficient quality to guide medical management decisions.
Study NCT05532514 — intervention group
Intervention type: OTHER
Intervention: MICRONUCLEI COUNT
Description: MICRONUCLEI COUNT IN PRECBCT and POSTCBCT EXPOSURE
Study NCT05396872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Participant Surveys
Description: Online surveys administered post appointment
Study NCT05396872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile app
Description: Mobile application installed on mobile device
Study NCT05336851 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker blood draw and saliva collection
Description: Three peripheral 10 - 20mL blood sample (if available) Three 1 - 5mL salivary samples (if available)
Study NCT05033951 — intervention group
Intervention type: OTHER
Intervention: Standard care
Description: Both groups: standard care+ questionnaires
Study NCT05897320 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eptinezumab
Description: Solution for infusion
Study NCT05897320 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Solution for infusion
Study NCT05305612 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: early anticoagulation
Description: Anticoagulation prior to transseptal puncture
Study NCT05305612 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: late anticoagulation
Description: Anticoagulation after transseptal puncture
Study NCT06233227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dutasteride-Test product
Description: Dutasteride soft capsule 0.5 mg Test product Manufactured by: Phil Inter Pharma Co., Ltd., Vietnam
Study NCT06233227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dutasteride-Reference product
Description: Dutasteride soft capsule 0.5 mg Reference product Manufactured by: DELPHARM POZNAN S.A., Poland
Study NCT06533358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT1002 Injection
Description: MT1002 is infused once only, once for 4h. MT1002 is for subjects with acute coronary syndrome undergoing PCI
Study NCT04615884 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chinese herbs formula: Shu Yu Wan
Description: Shu Yu Wan Formula is a combination of 23 natural chinese herbs.This formula may be used to relieve chemotherapeutic side effects or cancer-related symptoms.
Study NCT04615884 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsules
Description: Placebo
Study NCT05718063 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MAP for Coaches - Complete Course
Description: The MAP for Coaches is an eLearning (web-based) knowledge translation training course aimed at providing youth sport coaches with the evidence-based education and motivation they need to reduce the risk of musculoskeletal injuries in young athletes. Course modules include a description of: (1) musculoskeletal injuries in youth sport; (2) the importance of injury prevention, and instructions on: (1) applying best practices for musculoskeletal athletic injury prevention, including neuromuscular training programs; (2) using behavioral strategies to successfully implement neuromuscular training warm-up programs in coaching sessions.
Study NCT05718063 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Map for Coaches - Overview
Description: This is a summarized version of the MAP for Coaches. It comprises a 2-page sport-specific injury prevention e-book (reading) containing an overview of the MAP for Coaches training and an infographic summary.
Study NCT06515145 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High Volume Therapeutic Plasma Exchange
Description: Experimental- High Volume Therapeutic Plasma Exchange at (8 - 9 litres of plasma would be exchanged in each patient over 6 - 8 hours)
Study NCT06515145 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard volume therapeutic plasma exchange
Description: Active Comparator - The standard volume strategy would be performed centrifugation technique with Plasma volume varying from 1.5 - 2.5 times the plasma - volume along with Standard Medical Treatment.
Study NCT06330012 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: GeoMx data analysis with clinical outcome
Description: 1. List of HER2 positive breast cancer~   * Stage IV disease~  * Treated with T-Dxd~  * Available FFPE samples~2. Prepare tissue for digital spatial proteomics~   * FFPE/H\&E slide~  * Region of Interest(ROI) check~  * Make a Tissue microarray~  * Prepare special slide for GeoMx~3. GeoMx data analysis with clinical outcome
Study NCT05191940 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Particle-therapy using protons or carbon ions
Description: According to the radiation plan (between 25 and a maximum of 40 Gy). Planning Target Volume 1 : 25 Gy (Relative Biological Effectiveness) in 5 fractions of 5 Gy (Relative Biological Effectiveness) Planning Target Volume 2 : A simultaneous integrated boost (SIB) will be delivered to the Planning Target Volume 2: 40 Gy (Relative Biological Effectiveness) in 5 fractions of 8 Gy (Relative Biological Effectiveness).
Study NCT05191940 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Blood sampling
Description: Evaluation before treatment-start, after treatment and follow-up period.
Study NCT05191940 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Magnetic resonance imaging
Description: For treatment planning as well as for follow-up radiological tumor assessment.
Study NCT05191940 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Computertomography
Description: For treatment planning as well as for follow-up radiological tumor assessment.
Study NCT05191940 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)
Description: For treatment planning as well as for follow-up radiological tumor assessment.
Study NCT06057194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir 240 mg Oral Tablet
Description: Treatment will commence as soon as subjects can receive oral medication, with a maximum timeframe of 28 days after transplantation. If patients cannot receive oral medication after transplantation, initial prophylaxis with ganciclovir per clinical practice will be allowed. Medication will be discontinued 12 months after treatment initiation.
Study NCT04630184 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure intervention in virtual reality
Description: 6 sessions of 45 minutes weekly and 2 follow-up meetings (3 and 6 weeks after the weekly follow-up) with cognitive restructuring and VR exposure supervised by psychologists
Study NCT04630184 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: Participants will have to go twice a week, for 12 weeks to carry out 2 individual endurance training sessions of 45 minutes (moderate to vigorous intensity), supervised by a kinesiologist. Participants will also have to complete a 3rd 60-minute endurance session at home (or two 30-minute sessions).
Study NCT04630184 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will have to go twice a week, for 12 weeks to carry out 2 individual endurance training sessions of 45 minutes (moderate to vigorous intensity), supervised by a kinesiologist. Participants will also have to complete a 3rd 60-minute endurance session at home (or two 30-minute sessions).
Study NCT04630184 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 6 sessions of 45 minutes weekly and 2 follow-up meetings (3 and 6 weeks after the weekly follow-up) Discussion around social physical anxiety, stress management (relaxation and breathing) supervised by psychologists
Study NCT04701359 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TiN-alloy based total knee arthroplasty
Description: TiN-alloy based TKA implanted for knee osteoarthritis.
Study NCT04701359 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CoCr-coating based total knee arthroplasty
Description: CoCr-coating based TKA implanted for knee osteoarthritis.
Study NCT06003140 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Celsi Warmer
Description: A trained study clinician will attach the Celsi Warmer temperature sensor to the abdomen and secure it with the abdominal belt according to the device's instruction manual (such that the temperature sensor is positioned using a vertical line from the mid-clavicular line and just below the ribs). The time of sensor placement will be recorded.
Study NCT04714749 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovenous treatment
Description: Treatment of great saphenous vein (its tributaries and possible incompetent perforators feeding the ulcer) by endovascular cyanoacrylate glue
Study NCT04714749 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue
Description: Treatment of great saphenous vein (its tributaries and possible incompetent perforators feeding the ulcer) by endovascular cyanoacrylate glue
Study NCT06065683 — intervention group
Intervention type: PROCEDURE
Intervention: surgery
Description: Surgical procedures performed in the study period
Study NCT06502886 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: combined protocol of retention (bonded lingual retainer and vacuum formed retainers)
Description: Combined bonded retainer and vacuum formed retainer
Study NCT06502886 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bonded lingual retainer
Description: Bonded retainer
Study NCT05253287 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Growth Hormone
Description: GH therapy will be initiated at a low dose of 2U/day and titrated slowly based on IGF-1 levels) subcutaneously for 1 year.
Study NCT05507138 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AKL-T01
Description: AKL-T01 is an iPad-based video game designed to improve executive dysfunction and depression symptoms by targeting executive skills (multitasking) and ECN abnormalities.
Study NCT05507138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Metacognitive Strategy Training
Description: Metacognitive Strategy Training involves working with a clinician (neuropsychologist or occupational therapist) to learn strategies to manage cognitive difficulties
Study NCT05507138 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Metacognitive Strategy Training
Description: Metacognitive Strategy Training involves working with a clinician (neuropsychologist or occupational therapist) to learn strategies to manage cognitive difficulties